Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 456

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.
About This Bill
Committee
Latest Action · February 3, 2023
Referred to the Subcommittee on Health.
Introduced
January 24, 2023
Cosponsors (0)
None
View PDF ↗

Public Comments (0)

No comments yet. Be the first to weigh in from the Take Action box.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.